4//SEC Filing
Rochlin Kate 4
Accession 0001415889-25-003344
CIK 0001740279other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:15 PM ET
Size
5.7 KB
Accession
0001415889-25-003344
Insider Transaction Report
Form 4
IN8BIO, INC.INAB
Rochlin Kate
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-02-05+338,950→ 338,950 totalExercise: $0.29Exp: 2035-02-05→ Common Stock (338,950 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
IN8BIO, INC.
CIK 0001740279
Entity typeother
Related Parties
1- filerCIK 0001898521
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:15 PM ET
- Size
- 5.7 KB